Contribution of verbal suggestion to the therapeutic efficacy of an analgesic agent for acute primary headache

Cephalalgia

Volumn 35, Issue 7, 2015, Pages 579-584

  Oktay, Cem ^a   Eken, Cenker ^a   Goksu, Erkan ^a   Dora, Babur ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

analgesia; emergency department; expectancy; headache; nocebo; placebo; Verbal suggestions

Indexed keywords

ANALGESIC AGENT; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANALGESIA; ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DRUG EFFICACY; EMERGENCY WARD; FEAR; FEMALE; HEALTH BELIEF; HOPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCEBO EFFECT; PAIN ASSESSMENT; PLACEBO EFFECT; PRIMARY HEADACHE; PROSPECTIVE STUDY; SCORING SYSTEM; SOCIAL PSYCHOLOGY; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; VERBAL COMMUNICATION; VISUAL ANALOG SCALE; ACUTE DISEASE; HEADACHE DISORDERS, PRIMARY; MIDDLE AGED; PAIN MEASUREMENT; PROCEDURES; PSYCHOLOGY; SUGGESTION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANALGESICS; DICLOFENAC; FEMALE; HEADACHE DISORDERS, PRIMARY; HUMANS; MALE; MIDDLE AGED; PAIN MANAGEMENT; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SUGGESTION; TREATMENT OUTCOME;

EID: 84930517551     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102414553821     Document Type: Article

References (30)

1. Goldstein JN, Camargo CA, Pelletier AJ, et al. Headache in United States emergency departments: Demographics, work-up and frequency of pathological diagnoses. Cephalalgia. 2006 ; 26: 684-690
2. Edlow JA, Panagos PD, Godwin SA, et al. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache. Ann Emerg Med. 2008 ; 52: 407-436
3. Bounes V, Edlow JA. Migraine: Diagnosis and pharmacologic treatment in emergency department. Eur Rev Med Pharmacol Sci. 2011 ; 15: 215-221
4. Ramirez-Lassepas M, Espinosa CE, Cicero JJ, et al. Predictors of intracranial pathologic findings in patients who seek emergency care because of headache. Arch Neurol. 1997 ; 54: 1506-1509
5. Aukerman G, Knutson D, Miser WF. Management of the acute migraine headache. Am Fam Physician. 2001 ; 66: 2123-2130
6. Bendtsen L, Jensen R. Treating tension-type headache - an expert opinion. Expert Opin Pharmacother. 2011 ; 12: 1099-1109
7. Fosnocht DE, Swanson ER, Barton ED. Changing attitudes about pain and pain control in emergency medicine. Emerg Med Clin N Am. 2005 ; 23: 297-306
8. Fosnocht DE, Swanson ER, Bossart P. Patient expectations for pain medication delivery. Am J Emerg Med. 2001 ; 19: 399-402
9. Kuhn S, Cooke K, Collins M, et al. Perceptions of pain relief after surgery. BMJ. 1990 ; 300: 1687-1690
10. Spiegel H. Nocebo: The power of suggestibility. Prev Med. 1997 ; 26: 616-621
11. Guess HA, Kleinman A, Kusek JW, et al The science of the placebo: Toward an interdisciplinary research agenda. 1 st edn. London: BMJ Books, 2002, pp. 108-132. London: BMJ Books ; 2002: 108-132.
12. Miller FG, Rosenstein DL. The nature and power of the placebo effect. J Clin Epidemiol. 2006 ; 59: 331-335
13. Kennedy WP. The nocebo reaction. Med Exp Int J Exp Med. 1961 ; 95: 203-205
14. Benedetti F, Lanotte M, Lopiano L, et al. When words are painful: Unraveling the mechanisms of the nocebo effect. Neuroscience. 2007 ; 147: 260-271
15. Bingel U, Wanigasekera V, Wiech K, et al. The effect of treatment expectation on drug efficacy: Imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011 ; 3: 70ra14-70ra14
16. Kam-Hansen S, Jakubowski M, Kelley JM, et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014 ; 6: 218ra5-218ra5
17. Colman I, Rothney A, Wright SC, et al. Use of narcotic analgesics in the emergency department treatment of migraine headache. Neurology. 2004 ; 62: 1695-1700
18. Cete Y, Dora B, Ertan C, et al. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia. 2005 ; 25: 199-204
19. Thomas KB. The placebo in general practice. Lancet. 1994 ; 344: 1066-1067
20. Pollo A, Amanzio M, Arslanian A, et al. Response expectancies in placebo analgesia and their clinical relevance. Pain. 2001 ; 93: 77-84
21. Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain. 1983 ; 16: 129-143
22. Benedetti F, Amanzio M. The neurobiology of placebo analgesia: From endogenous opioids to cholecystokinin. Prog Neurobiol. 1997 ; 52: 109-125
23. Vase L, Robinson ME, Verne GN, et al. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain. 2003 ; 105: 17-25
24. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999 ; 19: 484-494
25. Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci. 1999 ; 19: 3639-3648
26. Price DD, Milling LS, Kirsch I, et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain. 1999 ; 83: 147-156
27. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003 ; 23: 4315-4323
28. Lautenbacher S, Spernal J, Schreiber W, et al. Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med. 1999 ; 61: 822-827
29. Friedman BW, Hochberg ML, Esses D, et al. Applying the International Classification of Headache Disorders to the emergency department: An assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentation. Ann Emerg Med. 2007 ; 49: 409-419
30. Kurowski M. Pharmacokinetics and biological availability of diclofenac preparations following intramuscular injection of 75 mg and oral administration of 150 mg of active drug [article in German]. Z Rheumatol. 1988 ; 47: 37-42